1. Bayer buying KaNDy for $425M to get menopause market — Putin says Russian COVID-19 vaccine will be ready January 1 — Eisai creating new US HQ in New Jersey — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Abandon Ship...?

Discussion in 'Santarus' started by Anonymous, May 13, 2014 at 2:01 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Now that the transition from Santarus to Salix has been complete for going on five months now, what are the thoughts of those that were not retained vs those that were transferred over to Salix? The horror stories keep pouring in about all the micromanaging taking place at Salix. Rumor has it that over 30% of those retained by Salix have already quit. Is that accurate?
     

  2. Anonymous

    Anonymous Guest

    Hopefully more quit- not many of the Santuarus folks are up to par. Good people but just not a good fit in a performance based company.
     
  3. Anonymous

    Anonymous Guest

    "Performance based"? Laughing my ass off at that one.

    Can't wait until the DOJ wails down the hammer on those Salix idiots.
     
  4. Anonymous

    Anonymous Guest


    Sounds like Salix HR is doing some additional detective work - can't believe the feedback from the exit interviews, huh?
     
  5. Anonymous

    Anonymous Guest

    It is performance based. Too bad it's a vaudeville performance. Bring in the clowns!